Board logo

subject: Disease and Therapy Review: Bladder Cancer [print this page]


Disease and Therapy Review: Bladder Cancer

TheBladder Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cancer market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and TherapyReview provides a conciseanalysis of the most important informationabout a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategiesand treatment options, general information about the market size, and information about important market trends. Thedata contained in these reportscomes fromkey industry secondary data sources,such asthe Timely Data Resources Incidence and Prevalence Database, andLange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites.Sources and references are provided.

I.OVERVIEW

General description of the condition

II.INCIDENCE AND PREVALENCE

Incidence Table (Canada, US, Mexico, France, Germany, Greece, Italy, Russian Federation, Spain, Sweden, UK, China, India, Japan, Europe, Worldwide)

Prevalence Table (Canada, US,Mexico,France,Germany,Italy,Spain,UK,China,India,Japan, Worldwide)

Mortality Table (Canada, US, Mexico, France, Germany, Greece, Italy, Russian Federation, Spain, Sweden, UK, China, India, Japan, Europe, Worldwide)

III.DIAGNOSIS

Symptoms and signs

Laboratory findings

Imaging

Cystouresthroscopy and biopsy

Cellular classification

IV. TREATMENT

Surgical therapy

Radiotherapy

Chemotherapy

Interstitial implantation of radioisotopes

Clinical trials

Outcomes by stage

V.DOSING AND TREATMENT COSTS

VI.MARKET SIZE

VII.COMMENTS

VIII.REFERENCES/RESOURCES




welcome to loan (http://www.yloan.com/) Powered by Discuz! 5.5.0